» Articles » PMID: 30482050

Opportunistic Screening Models for High-risk Men and Women to Detect Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction in the Community

Abstract

Background: The prevalence of undetected left ventricular diastolic dysfunction is high, especially in the elderly with comorbidities. Left ventricular diastolic dysfunction is a prognostic indicator of heart failure, in particularly of heart failure with preserved ejection fraction and of future cardiovascular and all-cause mortality. Therefore we aimed to develop sex-specific diagnostic models to enable the early identification of men and women at high-risk of left ventricular diastolic dysfunction with or without symptoms of heart failure who require more aggressive preventative strategies.

Design: Individual patient data from four primary care heart failure-screening studies were analysed (1371 participants, excluding patients classified as heart failure and left ventricular ejection fraction <50%).

Methods: Eleven candidate predictors were entered into logistic regression models to be associated with the presence of left ventricular diastolic dysfunction/heart failure with preserved ejection fraction in men and women separately. Internal-external cross-validation was performed to develop and validate the models.

Results: Increased age and β-blocker therapy remained as predictors in both the models for men and women. The model for men additionally consisted of increased body mass index, moderate to severe shortness of breath, increased pulse pressure and history of ischaemic heart disease. The models performed moderately and similarly well in men (c-statistics range 0.60-0.75) and women (c-statistics range 0.51-0.76) and the performance improved significantly following the addition of N-terminal pro b-type natriuretic peptide (c-statistics range 0.61-0.80 in women and 0.68-0.80 in men).

Conclusions: We provide an easy-to-use screening tool for use in the community, which can improve the early detection of left ventricular diastolic dysfunction/heart failure with preserved ejection fraction in high-risk men and women and optimise tailoring of preventive interventions.

Citing Articles

Epidemiology, Clinical Characteristics and Cause-specific Outcomes in Heart Failure with Preserved Ejection Fraction.

Kapelios C, Shahim B, Lund L, Savarese G Card Fail Rev. 2023; 9:e14.

PMID: 38020671 PMC: 10680134. DOI: 10.15420/cfr.2023.03.


Predicting heart failure with preserved ejection fraction: revisiting an old friend with new knowledge.

van der Boon R Eur Heart J Digit Health. 2023; 2(1):104-105.

PMID: 36711177 PMC: 9707879. DOI: 10.1093/ehjdh/ztab017.


Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart Failure.

Berezin A, Obradovic Z, Novikov E, Boxhammer E, Lichtenauer M, Berezin A Diagnostics (Basel). 2022; 12(12).

PMID: 36552947 PMC: 9776539. DOI: 10.3390/diagnostics12122940.


Sex and Gender Differences in Heart Failure.

Regitz-Zagrosek V Int J Heart Fail. 2022; 2(3):157-181.

PMID: 36262368 PMC: 9536682. DOI: 10.36628/ijhf.2020.0004.


Predictive Value of Monocyte Chemoattractant Protein-1 in the Development of Diastolic Dysfunction in Patients with Psoriatic Arthritis.

Bursac I, Kehler T, Drvar V, Babarovic E, Pejcinovic V, Barsic A Dis Markers. 2022; 2022:4433313.

PMID: 35692875 PMC: 9187441. DOI: 10.1155/2022/4433313.


References
1.
Aurigemma G, Gottdiener J, Shemanski L, GARDIN J, Kitzman D . Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol. 2001; 37(4):1042-8. DOI: 10.1016/s0735-1097(01)01110-x. View

2.
Moons K, Grobbee D . When should we remain blind and when should our eyes remain open in diagnostic studies?. J Clin Epidemiol. 2002; 55(7):633-6. DOI: 10.1016/s0895-4356(02)00408-0. View

3.
Redfield M, Jacobsen S, Burnett Jr J, Mahoney D, Bailey K, Rodeheffer R . Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003; 289(2):194-202. DOI: 10.1001/jama.289.2.194. View

4.
Hogg K, Swedberg K, McMurray J . Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004; 43(3):317-27. DOI: 10.1016/j.jacc.2003.07.046. View

5.
Rutten F, Cramer M, Grobbee D, Sachs A, Kirkels J, Lammers J . Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J. 2005; 26(18):1887-94. DOI: 10.1093/eurheartj/ehi291. View